Transaction in Own Shares

CVS Group plc

02 December 2025

 

02 December 2025

CVS GROUP plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

Transaction in own shares

CVS announces that on 01 December 2025 it purchased the following number of its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the terms of the share buyback programme announced on 24 October 2025 (the "Share Buyback Programme").

Date of purchase:	01/12/2025
Aggregate number of Ordinary Shares purchased:	24,380
Lowest price paid per share (GBp):	1,216.00
Highest price paid per share (GBp):	1,230.00
Volume weighted average price paid per share (GBp):	1,221.26

CVS intends to cancel all of the purchased Ordinary Shares.

Following settlement of the above purchases and cancellation of the Ordinary Shares purchased, CVS will have 71,038,131 Ordinary Shares in issue and holds no Ordinary Shares in treasury.

The total number of voting rights in CVS is therefore 71,038,131 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, CVS under the Financial Conduct Authority's Disclosure and Transparency Rules.

Since the commencement of the Share Buyback Programme, the Company has repurchased 702,652 Ordinary Shares in aggregate at a weighted average price of 1,215.70 pence per share.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), as it forms part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Berenberg as part of the Share Buyback Programme.

Individual transactions:

Number of Ordinary Shares purchased	Transaction price (GBp share)	Time of transaction (UK Time)	Transaction reference number	Trading Venue
460	1220	01/12/2025 08:18:20	1343423437085083	XLON
577	1218	01/12/2025 08:30:00	1343423437086574	XLON
257	1218	01/12/2025 09:02:05	1343423437089975	XLON
803	1220	01/12/2025 09:35:00	1343423437093273	XLON
288	1220	01/12/2025 09:36:11	1343423437093342	XLON
219	1220	01/12/2025 09:36:11	1343423437093343	XLON
331	1218	01/12/2025 09:43:40	1343423437093795	XLON
436	1218	01/12/2025 09:55:18	1343423437094684	XLON
112	1218	01/12/2025 09:56:01	1343423437094744	XLON
662	1222	01/12/2025 10:42:12	1343423437097500	XLON
94	1222	01/12/2025 10:42:12	1343423437097501	XLON
577	1220	01/12/2025 10:47:30	1343423437097853	XLON
120	1220	01/12/2025 10:47:33	1343423437097854	XLON
248	1220	01/12/2025 10:53:56	1343423437098182	XLON
294	1216	01/12/2025 10:54:06	1343423437098186	XLON
179	1216	01/12/2025 10:54:06	1343423437098187	XLON
735	1218	01/12/2025 11:05:05	1343423437098948	XLON
257	1218	01/12/2025 11:05:05	1343423437098950	XLON
478	1218	01/12/2025 11:05:05	1343423437098951	XLON
732	1218	01/12/2025 11:06:54	1343423437099051	XLON
732	1220	01/12/2025 11:13:09	1343423437099505	XLON
71	1218	01/12/2025 11:13:15	1343423437099509	XLON
71	1218	01/12/2025 11:13:21	1343423437099513	XLON
560	1220	01/12/2025 11:21:06	1343423437100114	XLON
771	1224	01/12/2025 12:05:48	1343423437103984	XLON
131	1222	01/12/2025 12:31:53	1343423437105501	XLON
80	1222	01/12/2025 12:31:53	1343423437105502	XLON
816	1220	01/12/2025 12:55:00	1343423437107024	XLON
826	1220	01/12/2025 12:55:00	1343423437107032	XLON
826	1218	01/12/2025 12:55:47	1343423437107085	XLON
71	1218	01/12/2025 13:01:19	1343423437107463	XLON
288	1224	01/12/2025 13:18:04	1343423437108804	XLON
200	1222	01/12/2025 13:45:07	1343423437111282	XLON
400	1222	01/12/2025 13:45:08	1343423437111283	XLON
41	1220	01/12/2025 13:50:26	1343423437111694	XLON
922	1220	01/12/2025 13:50:26	1343423437111695	XLON
200	1218	01/12/2025 13:50:32	1343423437111709	XLON
200	1218	01/12/2025 13:51:03	1343423437111754	XLON
971	1216	01/12/2025 13:52:00	1343423437111856	XLON
995	1216	01/12/2025 13:52:00	1343423437111857	XLON
559	1218	01/12/2025 13:52:58	1343423437111941	XLON
158	1218	01/12/2025 13:52:58	1343423437111942	XLON
1161	1220	01/12/2025 13:54:42	1343423437112080	XLON
653	1230	01/12/2025 15:34:26	1343423437128374	XLON
1	1230	01/12/2025 15:34:26	1343423437128375	XLON
64	1230	01/12/2025 15:34:31	1343423437128382	XLON
11	1230	01/12/2025 15:34:31	1343423437128383	XLON
1187	1228	01/12/2025 15:50:19	1343423437131054	XLON
84	1228	01/12/2025 15:50:21	1343423437131064	XLON
50	1228	01/12/2025 15:50:21	1343423437131065	XLON
7	1228	01/12/2025 15:50:21	1343423437131066	XLON
306	1228	01/12/2025 15:50:23	1343423437131070	XLON
330	1228	01/12/2025 15:59:41	1343423437132940	XLON
103	1228	01/12/2025 15:59:41	1343423437132945	XLON
111	1228	01/12/2025 15:59:41	1343423437132944	XLON
119	1228	01/12/2025 15:59:41	1343423437132943	XLON
158	1228	01/12/2025 15:59:41	1343423437132942	XLON
119	1228	01/12/2025 15:59:41	1343423437132941	XLON
8	1228	01/12/2025 16:01:24	1343423437133540	XLON
96	1228	01/12/2025 16:08:02	1343423437134985	XLON
191	1228	01/12/2025 16:08:02	1343423437134984	XLON
313	1228	01/12/2025 16:09:03	1343423437135203	XLON
199	1228	01/12/2025 16:09:03	1343423437135206	XLON
471	1228	01/12/2025 16:09:03	1343423437135204	XLON
24	1228	01/12/2025 16:09:03	1343423437135207	XLON
175	1228	01/12/2025 16:09:09	1343423437135224	XLON
270	1228	01/12/2025 16:15:03	1343423437136545	XLON
421	1228	01/12/2025 16:15:03	1343423437136546	XLON

Contacts

CVS Group plc                                                                                                                                                 via Camarco

Richard Fairman, CEO

Robin Alfonso, CFO

Paul Higgs, Chief Veterinary Officer

Charlotte Page, Head of Investor Relations

Peel Hunt LLP (Nominated Adviser & Joint Broker)                                                                             [phone]

Christopher Golden / James Steel / Andrew Clark

Berenberg (Joint Broker)                                                                                                                         [phone]

Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing

Camarco (Financial PR)                                                                                                                           [e-mail]

Ginny Pulbrook                                                                                                                                            [phone]

Letaba Rimell

Tilly Butcher

About CVS Group plc (www.cvsukltd.co.uk)

CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia.  CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

 

END